Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Probiotics in inflammatory bowel disease: is it all gut flora modulation?

Literature DB >> 15082574

Probiotics in inflammatory bowel disease: is it all gut flora modulation?

S Ghosh¹, D van Heel, R J Playford.

Abstract

Entities: Disease

Mesh：

Year: 2004 PMID： 15082574 PMCID： PMC1774052 DOI： 10.1136/gut.2003.034249

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

27 in total

1. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors: N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal: Gut Date: 2002-11 Impact factor: 23.059

Review 2. Bioactive natural compounds for the treatment of gastrointestinal disorders.

Authors: Subrata Ghosh; Raymond J Playford
Journal: Clin Sci (Lond) Date: 2003-06 Impact factor: 6.124

3. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis.

Authors: Daniel Rachmilewitz; Fanny Karmeli; Kenji Takabayashi; Tomoko Hayashi; Leonor Leider-Trejo; Jongdae Lee; Lorenzo M Leoni; Eyal Raz
Journal: Gastroenterology Date: 2002-05 Impact factor: 22.682

4. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.

Authors: L A Dieleman; M S Goerres; A Arends; D Sprengers; C Torrice; F Hoentjen; W B Grenther; R B Sartor
Journal: Gut Date: 2003-03 Impact factor: 23.059

5. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

Authors: A Venturi; P Gionchetti; F Rizzello; R Johansson; E Zucconi; P Brigidi; D Matteuzzi; M Campieri
Journal: Aliment Pharmacol Ther Date: 1999-08 Impact factor: 8.171

6. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

Authors: J Boudeau; A-L Glasser; S Julien; J-F Colombel; A Darfeuille-Michaud
Journal: Aliment Pharmacol Ther Date: 2003-07-01 Impact factor: 8.171

7. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis.

Authors: Ville Veckman; Minja Miettinen; Sampsa Matikainen; Roberto Lande; Elena Giacomini; Eliana M Coccia; Ilkka Julkunen
Journal: J Leukoc Biol Date: 2003-09 Impact factor: 4.962

8. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

Authors: Daniel Rachmilewitz; Kyoko Katakura; Fanny Karmeli; Tomoko Hayashi; Constantin Reinus; Bernard Rudensky; Shizuo Akira; Kiyoshi Takeda; Jongdae Lee; Kenji Takabayashi; Eyal Raz
Journal: Gastroenterology Date: 2004-02 Impact factor: 22.682

9. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers.

Authors: Michael Schultz; Hans-Jörg Linde; Norbert Lehn; Kurt Zimmermann; Johannes Grossmann; Werner Falk; Jürgen Schölmerich
Journal: J Dairy Res Date: 2003-05 Impact factor: 1.904

10. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

Authors: J McCarthy; L O'Mahony; L O'Callaghan; B Sheil; E E Vaughan; N Fitzsimons; J Fitzgibbon; G C O'Sullivan; B Kiely; J K Collins; F Shanahan
Journal: Gut Date: 2003-07 Impact factor: 23.059

30 in total

10. Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice.

Authors: Rohit Sharma; Rajeev Kapila; Gulshan Dass; Suman Kapila
Journal: Age (Dordr) Date: 2014-07-19

Probiotics in inflammatory bowel disease: is it all gut flora modulation?

1. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Review 2. Bioactive natural compounds for the treatment of gastrointestinal disorders.

3. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis.

4. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.

5. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

6. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

7. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis.

8. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

9. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers.

10. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

Review 1. Microbes, immunoregulation, and the gut.

2. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

Review 3. What is the origin of ulcerative colitis? Still more questions than answers.

4. The role of the gut microbiota in nonalcoholic fatty liver disease.

5. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.

6. Cytoprotective agent in Lactobacillus bulgaricus extracts.

Review 7. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

8. Microbiota of Inflammatory Bowel Disease Models.

9. Irritable bowel syndrome: bacteria and inflammation--clinical relevance now.

10. Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice.